As of 2025-07-16, the Intrinsic Value of Ayurcann Holdings Corp (AYUR.CN) is 0.05 CAD. This AYUR.CN valuation is based on the model Discounted Cash Flows (Growth Exit 10Y). With the current market price of 0.03 CAD, the upside of Ayurcann Holdings Corp is 103.00%.
The range of the Intrinsic Value is 0.01 - 0.23 CAD
Based on its market price of 0.03 CAD and our intrinsic valuation, Ayurcann Holdings Corp (AYUR.CN) is undervalued by 103.00%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (0.08) - (0.05) | (0.06) | -325.3% |
| DCF (Growth 10y) | 0.01 - 0.23 | 0.05 | 103.0% |
| DCF (EBITDA 5y) | (0.03) - (0.02) | (1,234.50) | -123450.0% |
| DCF (EBITDA 10y) | 0.01 - 0.03 | 0.02 | -29.8% |
| Fair Value | -0.10 - -0.10 | -0.10 | -501.29% |
| P/E | (0.24) - (0.24) | (0.24) | -1061.1% |
| EV/EBITDA | (0.35) - (0.38) | (0.35) | -1516.1% |
| EPV | (0.19) - (0.24) | (0.21) | -959.1% |
| DDM - Stable | (0.26) - (1.28) | (0.77) | -3166.3% |
| DDM - Multi | (0.05) - (0.19) | (0.08) | -418.3% |
| Market Cap (mil) | 4.87 |
| Beta | -1.42 |
| Outstanding shares (mil) | 194.70 |
| Enterprise Value (mil) | 9.94 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.46% |
| Cost of Debt | 5.00% |
| WACC | 6.87% |